References
- Borer A, Saidel-Odes L, Riesenberg K, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009;30(10):972–976. doi:10.1086/605922
- Dickstein Y, Edelman R, Dror T, Hussein K, Bar-Lavie Y, Paul M. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. J Hosp Infect. 2016;94(1):54–59. doi:10.1016/j.jhin.2016.05.018
- Salomao MC, Freire MP, Boszczowski I, et al. Increased risk for carbapenem-resistant enterobacteriaceae colonization in intensive care units after hospitalization in emergency department. Emerg Infect Dis. 2020;26(6):1156–1163. doi:10.3201/eid2606.190965
- Dutcher L, Lautenbach E. A deeper dive: implications of identifying more of the carbapenem-resistant Enterobacteriaceae iceberg. J Infect Dis. 2020;221(11):1743–1745. doi:10.1093/infdis/jiz290
- Magiorakos AP, Burns K, Rodriguez Bano J, et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control. Antimicrob Resist Infect Control. 2017;6(1):113. doi:10.1186/s13756-017-0259-z
- Komurcu B, Tukenmez Tigen E, Toptas T, et al. Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study. Expert Rev Hematol. 2020;13(8):923–927. doi:10.1080/17474086.2020.1787145
- Weinstock DM, Conlon M, Iovino C, et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2007;13(5):615–621. doi:10.1016/j.bbmt.2007.01.078
- Trecarichi EM, Pagano L, Martino B, et al. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey. Am J Hematol. 2016;91(11):1076–1081. doi:10.1002/ajh.24489
- van Loon K, Voor In ‘t Holt AF, Vos MC. A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2018;62(1). doi:10.1128/AAC.01730-17
- Castagnola E, Tatarelli P, Mesini A, et al. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity. J Infect Public Health. 2019;12(2):270–274. doi:10.1016/j.jiph.2018.11.003
- Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI supplement M100. PA: Clinical and Laboratory Standards InstituteWayne; 2018
- Huang PH, Chen WY, Chou SH, et al. Risk factors for the development of colistin resistance during colistin treatment of carbapenem-resistant Klebsiella pneumoniae infections. Microbiol Spectr. 2022;10(3):e0038122. doi:10.1128/spectrum.00381-22
- Tamma PD, Simner PJ. Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol. 2018;56(11). doi:10.1128/JCM.01140-18
- Kiaei S, Moradi M, Hosseini Nave H, et al. Emergence of co-existence of blaNDM with rmtC and qnrB genes in clinical carbapenem-resistant Klebsiella pneumoniae isolates in burning center from southeast of Iran. Folia Microbiol (Praha). 2019;64(1):55–62. doi:10.1007/s12223-018-0630-3
- Smith JL, Drum DJ, Dai Y, et al. Impact of antimicrobial usage on antimicrobial resistance in commensal Escherichia coli strains colonizing broiler chickens. Appl Environ Microbiol. 2007;73(5):1404– 1414. doi:10.1128/AEM.01193-06
- Prasad N, Labaze G, Kopacz J, et al. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City. Am J Infect Control. 2016;44(5):525–532. doi:10.1016/j.ajic.2015.11.021
- Zaidah AR, Mohammad NI, Suraiya S, et al. High burden of carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting. Antimicrob Resist Infect Control. 2017;6(1):42. doi:10.1186/s13756-017-0200-5
- Freire MP, Oshiro IC, Pierrotti LC, et al. Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101(4):811–820. doi:10.1097/TP.0000000000001620
- Collingwood A, Blostein F, Seekatz AM, et al. Epidemiological and microbiome associations between Klebsiella pneumoniae and vancomycin-resistant Enterococcus colonization in intensive care unit patients. Open Forum Infect Dis. 2020;7(1):ofaa012. doi:10.1093/ofid/ofaa012
- Kim YK, Song SA, Lee JN, et al. Clinical factors predicting persistent carriage of Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients with known carriage. J Hosp Infect. 2018;99(4):405–412. doi:10.1016/j.jhin.2017.10.017
- Ni W, Han Y, Liu J, et al. Tigecycline treatment for carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. Medicine. 2016;95(11):e3126. doi:10.1097/MD.0000000000003126
- Demirlenk YM, Gucer LS, Ucku D, et al. A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Eur J Clin Microbiol Infect Dis. 2022;41(5):761–769. doi:10.1007/s10096-022-04429-0
- Macesic N, Gomez-Simmonds A, Sullivan SB, et al. Genomic surveillance reveals diversity of multidrug-resistant organism colonization and infection: a prospective cohort study in liver transplant recipients. Clin Infect Dis. 2018;67(6):905–912. doi:10.1093/cid/ciy199
- Hussein K, Rabino G, Eluk O, et al. The association between infection control interventions and carbapenem-resistant Enterobacteriaceae incidence in an endemic hospital. J Hosp Infect. 2017;97(3):218–225. doi:10.1016/j.jhin.2017.07.018